AU2003292838A1 - Therapeutic agent for wet age-related macular degeneration - Google Patents

Therapeutic agent for wet age-related macular degeneration

Info

Publication number
AU2003292838A1
AU2003292838A1 AU2003292838A AU2003292838A AU2003292838A1 AU 2003292838 A1 AU2003292838 A1 AU 2003292838A1 AU 2003292838 A AU2003292838 A AU 2003292838A AU 2003292838 A AU2003292838 A AU 2003292838A AU 2003292838 A1 AU2003292838 A1 AU 2003292838A1
Authority
AU
Australia
Prior art keywords
therapeutic agent
macular degeneration
related macular
wet age
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003292838A
Other languages
English (en)
Other versions
AU2003292838A8 (en
Inventor
Shinji Koyama
Kiyoshi Matsuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of AU2003292838A8 publication Critical patent/AU2003292838A8/xx
Publication of AU2003292838A1 publication Critical patent/AU2003292838A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2003292838A 2002-12-27 2003-12-26 Therapeutic agent for wet age-related macular degeneration Abandoned AU2003292838A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-379857 2002-12-27
JP2002379857 2002-12-27
PCT/JP2003/016854 WO2004060373A1 (ja) 2002-12-27 2003-12-26 滲出型加齢黄斑変性治療剤

Publications (2)

Publication Number Publication Date
AU2003292838A8 AU2003292838A8 (en) 2004-07-29
AU2003292838A1 true AU2003292838A1 (en) 2004-07-29

Family

ID=32708412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003292838A Abandoned AU2003292838A1 (en) 2002-12-27 2003-12-26 Therapeutic agent for wet age-related macular degeneration

Country Status (2)

Country Link
AU (1) AU2003292838A1 (ja)
WO (1) WO2004060373A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004035572A1 (ja) * 2002-10-21 2004-04-29 Kirin Beer Kabushiki Kaisha N−{2−クロロ−4−[(6,7−ジメトキシ−4−キノリル)オキシ]フェニル}−n’−(5−メチル−3−イソキサゾリル)ウレアの塩の結晶形
DK2392564T3 (da) 2003-09-26 2014-01-13 Exelixis Inc c-Met-modulatorer og anvendelsesfremgangsmåder
SG173014A1 (en) 2009-01-16 2011-08-29 Exelixis Inc Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
UA108618C2 (uk) 2009-08-07 2015-05-25 Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
WO2012044572A1 (en) 2010-09-27 2012-04-05 Exelixis, Inc. Dual inhibitors of met and vegf for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases
GB2516561B (en) * 2013-03-15 2016-03-09 Aerpio Therapeutics Inc Compositions, formulations and methods for treating ocular diseases
EP3513809B9 (en) * 2016-09-13 2022-07-13 Kyowa Kirin Co., Ltd. Medicinal composition comprising tivozanib

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025171A1 (en) * 1995-02-16 1996-08-22 F.Hoffmann-La Roche Ag Inhibition of angiogenesis using interleukin-12
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
DE69925578T2 (de) * 1998-03-05 2006-04-27 Senju Pharmaceutical Co., Ltd. Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
JP2001114699A (ja) * 1999-08-12 2001-04-24 Santen Pharmaceut Co Ltd キマーゼ阻害作用を有する化合物を有効成分とする血管新生阻害剤
EP1267935A2 (en) * 2000-01-12 2003-01-02 Light Sciences Corporation Novel treatment for eye disease
DK1382604T3 (da) * 2001-04-27 2006-04-18 Kirin Brewery Quinolinderivater med en azolylgruppe og quinazolinderivater

Also Published As

Publication number Publication date
WO2004060373A1 (ja) 2004-07-22
AU2003292838A8 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
EP1461028A4 (en) TREATMENT OF MACULAR DEGENERATION WITH AGING
HRP20050163A2 (en) Combination therapy for hyperproliferative diseases
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AU2003273865A1 (en) Amino-propanol derivatives
AU2003224654A1 (en) Photodynamic therapy for pre-melanomas
AU2003256378A1 (en) Therapeutic pack
AU2003279911A1 (en) Therapeutic formulations
AU2003268672A1 (en) Drug absorbability improving agents
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
AU2003220917A1 (en) Phospholipid derivative
SI1464341T1 (sl) Vodotopna formulacija, ki vsebuje ubikinon, za očesno uporabo
AU2003292838A1 (en) Therapeutic agent for wet age-related macular degeneration
AU2003224000A1 (en) Compounds useful as photodynamic therapeutic agents
AU2003282722A1 (en) Therapeutic compositions
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003243997A1 (en) Therapeutic agent for brain hemorrhage
AU2002226683A1 (en) Complex therapy for tissue regeneration
AU2003273387A1 (en) Abt-anti-bedsore timer
AU2003266714A1 (en) Phospholipid derivative
AU2003304364A1 (en) Applicator for footwear
AU2003242246A1 (en) Remedy for bone mtabolic diseases
AU2003248679A1 (en) Treating disease using radium-225
AU2003213349A1 (en) Therapeutic agent for pain
AU2003296060A1 (en) Ophthalmic therapeutic composition
AU2003906647A0 (en) Therapeutic Agents

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 34, PAGE(S) 8901 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME SANTEN PHARMACEUTICAL CO., LTD., APPLICATION NO. 2003292838, UNDER INID (71) CORRECT THE NAME TO READ KIRIN BEER KABUSHIKI KAISHA; SANTEN PHARMACEUTICAL CO., LTD.

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase